Ligand validation:5E32

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5E32 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5E32_NAG_A_1001	52%	79%	0.121	0.878	0.36	0.51	-	-	0	0	100%	0.9333
5E32_NAG_A_1002	38%	72%	0.214	0.919	0.54	0.55	-	-	0	0	100%	0.9333
5E32_NAG_A_1003	9%	82%	0.422	0.924	0.42	0.38	-	-	0	0	100%	0.9333
5E35_NAG_A_1002	62%	75%	0.133	0.924	0.45	0.52	-	-	0	0	100%	0.9333
5E34_NAG_A_1002	61%	67%	0.136	0.926	0.76	0.51	1	-	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_B_501	100%	64%	0.02	0.995	0.38	0.97	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.